Panacea Biotec Ltd Share Price
(PANACEABIO)
₹435.6▲0.99%
as on 11:35AM, 26 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 43.28 % |
3 Month Return | -3.97 % |
1 Year Return | + 241.26 % |
Market Stats | |
Previous Close | ₹431.35 |
Open | ₹440.75 |
Volume | 80.99K |
Upper Circuit | ₹452.90 |
Lower Circuit | ₹409.80 |
Market Cap | ₹2,642.05Cr |
P/E Ratio
-329.27
PEG Ratio
-506.58
Market Cap
₹2,642.05 Cr
P/B Ratio
2.42
EPS
-0.25
Dividend Yield
0Sector
Pharmaceuticals
ROE
0.86
Panacea Biotec Reports Strong Profit Growth - 12 Mar, 2025
Panacea Biotec Reports Strong Financial Growth - 04 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
Foreign Institutions have increased holdings from 0.37% to 0.38% in Dec 2024 quarter
Best in 3 Years
In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Up
Retail Investor have increased holdings from 25.60% to 25.97% in Dec 2024 quarter
Price Rise
In the last 1 month, PANACEABIO stock has moved up by 43.3%
Revenue Rich
Revenue is up for the last 3 quarters, 122.26 Cr → 169.88 Cr (in ₹), with an average increase of 15.0% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 4.8 Cr → 4.52 Cr (in ₹), with an average decrease of 5.8% per quarter
Promoter Holding Down
Promoters have decreased holdings from 72.87% to 72.49% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.49% | ||
Foreign Institutions | 0.38% | 2.99 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 25.97% | 1.43 | |
Others | 1.17% | 0.28 |
Panacea Biotec in the last 5 years
Lowest (-915.62x)
April 25, 2024
Today (-329.27x)
March 25, 2025
Industry (54.31x)
March 25, 2025
Highest (113.15x)
October 5, 2023
Panacea Biotec Ltd’s net profit jumped 298.25% since last year same period to ₹4.52Cr in the Q3 2024-2025. On a quarterly growth basis, Panacea Biotec Ltd has generated -5.83% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Panacea Biotec Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹2,642.05 Cr | 69.86% | 0.65 | -₹2 Cr | ₹559 Cr | |
NA | ₹4,992.12 Cr | 11.51% | 0.79 | -₹388 Cr | ₹75 Cr | |
NA | ₹104.00 Cr | -3.08% | 0.60 | NA | NA | |
NA | ₹71.57 Cr | 150.49% | 0.80 | NA | NA | |
NA | ₹276.72 Cr | 23.25% | 0.60 | ₹5 Cr | ₹173 Cr |
Organisation | Panacea Biotec |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Panacea Biotec Ltd share price today stands at ₹435.6, Open: ₹440.75, Previous Close: ₹431.35, High: ₹446.95, Low: ₹427.95, 52 Week High: ₹490.55, 52 Week Low: ₹112.35.
Today's traded volume of Panacea Biotec Ltd(PANACEABIO) is 80.99K.
Today's market capitalisation of Panacea Biotec Ltd(PANACEABIO) is ₹2642.05Cr.
Panacea Biotec Ltd (PANACEABIO) share price is ₹435.6. It is down -11.20% from its 52 Week High price of ₹490.55
Panacea Biotec Ltd (PANACEABIO) share price is ₹435.6. It is up 287.72% from its 52 Week Low price of ₹112.35